CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −4,470 | $13.17 | $59K | 279,422 |
| 2017-08-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −3,179 | $12.28 | $39K | 283,892 |
| 2017-05-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −3,176 | $11.86 | $38K | 287,071 |
| 2017-02-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −5,860 | $12.04 | $71K | 287,747 |
| 2017-01-17 | Faerm Michael E. Sr VP & Chief Business Officer | Grant or award | +133,398 | 293,607 | ||
| 2016-11-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −2,893 | $10.91 | $32K | 160,209 |
Page 1 of 1 · 6 trades